Recent updates in who classification of cans tumors and crush and squash preparation md pathology exam 10 marks

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching the Web

WHO classification of CNS tumors 5th edition 2021 major changes molecular

Finding Sources
Finding Sources
Searching the Web

squash smear technique brain tumor cytology intraoperative diagnosis pathology steps

1. Recent Updates in WHO Classification of CNS Tumors (WHO CNS5, 2021) — 10 Marks

Introduction

The WHO Classification of Tumors of the Central Nervous System, 5th edition (WHO CNS5, 2021), is the sixth version of the international standard for classifying brain and spinal cord tumors. It builds on the 2016 revised 4th edition and incorporates the recommendations of the cIMPACT-NOW (Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy) consensus updates.

Major General Changes

1. Advances the role of molecular diagnostics
  • Over 40 tumor types/subtypes are now defined chiefly by their molecular features rather than histology alone.
  • Layered/integrated diagnosis is mandated: histological classification, WHO grade, and molecular information are combined into a single integrated diagnostic line, with each parameter listed below it.
2. Grading changes
  • CNS tumor grading is now done within tumor types (e.g., astrocytoma, IDH-mutant can be grade 2, 3 or 4) rather than across entirely separate entities.
  • Arabic numerals (1, 2, 3, 4) replace Roman numerals (I, II, III, IV).
  • The term "anaplastic" is discouraged for grade 3 designation (e.g., oligodendroglioma grading no longer uses a strict mitotic count cut-off).
3. New nomenclature principles
  • "NOS" (Not Otherwise Specified) used when molecular testing has not been/cannot be done.
  • "NEC" (Not Elsewhere Classified) used when testing was done but the result doesn't fit any WHO-defined type.
4. New diagnostic technology
  • DNA methylome profiling is incorporated for defining some novel tumor types and subtypes.

Key Specific Changes by Category

CategoryMajor Change
Adult-type diffuse gliomasReduced to 3 types: astrocytoma IDH-mutant; oligodendroglioma IDH-mutant + 1p/19q-codeleted; glioblastoma IDH-wildtype. "Glioblastoma" is now reserved only for IDH-wildtype tumors. IDH-mutant astrocytoma with CDKN2A/B homozygous deletion is automatically grade 4.
Pediatric-type diffuse gliomasNew supercategories: pediatric-type diffuse low-grade glioma and pediatric-type diffuse high-grade glioma (e.g., diffuse midline glioma, H3 K27-altered; diffuse hemispheric glioma, H3 G34-mutant).
Circumscribed astrocytic gliomasNew grouping for pilocytic astrocytoma, pleomorphic xanthoastrocytoma, subependymal giant cell astrocytoma, etc.
EpendymomasReclassified by molecular/anatomic site: supratentorial (ZFTA-fusion, YAP1-fusion), posterior fossa (Group PFA, PFB), and spinal (MYCN-amplified) subtypes.
MedulloblastomaMolecularly defined groups: WNT-activated, SHH-activated (TP53-wildtype/mutant), non-WNT/non-SHH (Groups 3 and 4).
MeningiomasRemains one type with 15 subtypes, but grading now incorporates molecular markers (e.g., TERT promoter mutation, CDKN2A/B deletion mandate grade 3).
Embryonal tumorsNew entities like CNS neuroblastoma, FOXR2-activated; CNS tumor with BCOR internal tandem duplication.
Sellar region tumorsPituitary neuroendocrine tumor (PitNET) terminology introduced, replacing "pituitary adenoma" in some contexts.

Clinical/Academic Significance

  • Improves reproducibility of diagnosis and prognostication.
  • Guides targeted therapy and clinical trial stratification (e.g., IDH-inhibitors for IDH-mutant gliomas).
  • Requires close integration between neuropathology and molecular diagnostic laboratories, which has resource implications especially in low-resource settings.
(Ref: Louis DN et al., "The 2021 WHO Classification of Tumors of the Central Nervous System: a summary," Neuro-Oncology 2021 - PMC8328013)

2. Crush and Squash Preparation — 10 Marks

Definition

Crush (squash) preparation is a rapid intraoperative cytological technique in which a small fragment of fresh, unfixed tissue is gently compressed ("squashed") between two glass slides to disperse individual cells and small clusters for immediate microscopic examination, most classically used for intraoperative diagnosis of CNS/brain tumors, and also for rapid diagnosis of parasitic infections in tissue (e.g., cysticercosis, trichinellosis) and organisms like Donovan bodies in granuloma inguinale.

Indications

  1. Neurosurgical intraoperative consultation (most important use) - rapid diagnosis of brain/spinal cord lesions when a decision on extent of resection is needed on-table.
  2. Lymph node and soft tissue rapid cytology.
  3. Parasitology - crush preparation of muscle for Trichinella spiralis larvae, cysticercus, or of tissue/scrapings for Donovania granulomatis (Donovan bodies) and Schistosoma ova.
  4. Superficial nodules/lesions when frozen section facility or time is limited.

Procedure (Technique)

  1. A 1-2 mm representative, fresh fragment of tissue is taken (avoid necrotic/hemorrhagic areas; take from the periphery/interface of the lesion where cellularity is best).
  2. The fragment is placed on one clean glass slide; a second slide is placed over it at a right angle or directly on top.
  3. Gentle, even pressure is applied (never a shearing/dragging motion) to compress and spread the tissue into a thin monolayer film - excessive force causes crush artifact and nuclear distortion.
  4. The two slides are pulled apart smoothly, giving two smears.
  5. One slide is immediately wet-fixed in 95% ethanol (for Hematoxylin & Eosin or Papanicolaou stain); the other may be air-dried for rapid Toluidine blue/Diff-Quik stain, or a portion is submitted for simultaneous frozen section.
  6. Staining and reporting are completed typically within 10-20 minutes, and results are communicated to the surgeon while the patient is still on the table.

Advantages over Frozen Section

  • Preserves nuclear cytomorphological detail (chromatin pattern, nucleoli) far better - no ice-crystal artifact.
  • Technically simple, fast, and inexpensive - no cryostat required.
  • Very useful for soft, gliotic, or highly cellular CNS tissue that fragments poorly on freezing (e.g., lymphoma, glioma, medulloblastoma, pituitary adenoma).
  • Better demonstration of cell dissociation patterns that help distinguish glial vs neuronal vs mesenchymal tumors.

Limitations

  • Architectural/histoarchitectural detail is lost (cannot assess true tissue pattern, invasion, or vascular arrangement well) - frozen section or paraffin section still needed for definitive architecture-based diagnosis.
  • Poor performance for fibrous, calcified, or firm tumors (e.g., meningioma with heavy collagen, chordoma) which do not smear well - "crush resistant" tissue.
  • Cannot always distinguish tumor grade reliably.
  • Operator-dependent; overzealous pressure produces crush artifact mimicking hyperchromasia/malignancy.
  • Best used as a complement to frozen section, not a total replacement, especially in ambiguous or low-grade lesions.

Typical Cytomorphological Patterns Seen (CNS)

  • Astrocytoma: fibrillary background, elongated glial processes, uniform oval nuclei.
  • Glioblastoma: pleomorphic cells, necrosis, endothelial proliferation, high N:C ratio.
  • Meningioma: whorled clusters, psammoma bodies, nuclear pseudoinclusions.
  • Medulloblastoma/PNET: small round blue cells with high N:C ratio, "carrot/comet-shaped" nuclei, apoptosis.
  • Schwannoma: spindle cells with wavy/buckled nuclei (Antoni A/B pattern).
  • Pituitary adenoma: monomorphic round cells in acinar/trabecular pattern, salt-and-pepper chromatin.

Conclusion

Squash/crush smear cytology remains a cornerstone rapid intraoperative technique in neuropathology, offering excellent cytological detail with speed and simplicity, and is frequently combined with frozen section for the most accurate intraoperative diagnosis. (Ref: PMC5402488 - Intraoperative Squash Smear in CNS Tumors; PMC4253164 - Squash Cytology in Neurosurgical Practice)

Recent evidence check: A recent PMC study (2024, ScienceDirect) confirms squash smear cytology provides better nuclear morphology demonstration than frozen section for CNS lesion diagnosis, consistent with the classical teaching above - no contradicting recent evidence found. For CNS classification, WHO CNS5 (2021) remains current; no newer WHO edition has superseded it as of now, though ongoing cIMPACT-NOW updates continue to refine entities pending the next edition.
This is a shared conversation. Sign in to Orris to start your own chat.